A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2005

Primary Completion Date

June 25, 2007

Study Completion Date

June 25, 2007

Conditions

Advanced Solid Tumors

Interventions

DRUG

Tarceva, erlotinib, OSI-774

Trial Locations (5)

UPMC Cancer Pavilion, Pittsburgh

Mayo Clinic, Rochester

University of Colorado Health Sciences Center, Aurora

Premiere Oncology, Santa Monica

The Beatson West of Scotland Cancer Centre, Glasgow